Select Recent Financing Transactions

• Represented AbraSilver Resource Corp. in multiple transactions, including in connection with a $43 million bought deal LIFE private placement; $20 million non-brokered strategic private placement with Kinross Gold Corporation and an affiliate of Central Puerto SA; $30 million bought deal public offering of common shares and concurrent $28.5 million private placement of common shares, for aggregate gross proceeds of approximately $58.5 million.
• Represented Satellos Bioscience, Inc. in connection with a number of transformative financing transactions, including its US$57 million public offering in the US and Canada and concurrent listing on the Nasdaq Global Market.
• Represented Profound Medical in multiple Canadian and US financings, including in connection with its USD$36 million prospectus offering of common shares and its USD$40.25 million cross-border prospectus offering of common shares.
• Represented Silver Mountain Resources Inc. in multiple transactions, including in connection with a $25 million bought deal public offering of common shares.
• Represented Conavi Medical Inc. in multiple transactions, including in connection with a $12 million public offering of common shares and pre-funded warrants.
• Represented Haywood Securities Inc. as agent for Cresco Labs Inc.’s $140 million at-the-market equity offering program.
• Represented Canaccord Genuity and the syndicate of underwriters in PharmaCorp RX Inc.’s $23 million bought deal public offering.
• Represented Raymond James and a syndicate of underwriters in Blackrock Silver Corp.’s $13.8 million bought deal public offering.
• Represented Stifel Nicolaus and a syndicate of underwriters in Xtract One Technologies Inc.’s $10 million bought deal public offering.
• Represented Research Capital as underwriter in American Critical Minerals Corp.’s $4 million bought deal LIFE private placement.
• Represented ATB Capital Markets and Canaccord Genuity Corp. as agents for Glass House Brands Inc.’s US$25 million at-the-market equity offering program.
• Represented Research Capital Corp. and HC Wainwright & Co. as agents for PowerBank Corp.’s US$50 million cross-border at-the-market equity offering program.
• Represented Stifel Nicolaus as underwriter in NervGen Pharma Corp.’s $23 million bought deal public offering of common shares.
• Represented Titan Partners Group LLC as underwriter in connection with the A2Z Cust2Mate Solutions US$30 million public offering.
• Represented Leede Jones Gable Inc., as agent, in connection with ProMIS Neurosciences Inc.’s $20 million public offering of units.
• Represented ATB Capital Markets as agent for Nova Cannabis Inc.’s $20 million at-the-market equity offering program.
• Represented Institutional lenders on High Tide Inc.’s $15 million subordinated convertible debenture financing.

Select Recent M&A & Transactional Matters

• Represented Sierra Metals in connection with the all-cash unsolicited takeover bid received from Alpayana S.A.C.
• Represented Entourage Health in connection with its take-private transaction and sale to an affiliate of the LiUNA Pension Fund of Central and Eastern Canada.
• Represented Wellford Holdings Ltd. (formerly Cannaray) in connection with its proposed business combination with Aqualitas, a GMP-certified Canadian licensed cannabis producer, to create an international vertically integrated cannabis distributor.
• Represented Special Committee of Independent Directors of LifeSpeak Inc. in connection with its take-private transaction and sale.
• Represented Special Committee of Independent Directors of UGE International Ltd. in connection with its sale to NOVA Infrastructure Fund.
• Represented Northampton Capital Partners LLC in connection with its acquisition of a 43% interest in Altius Renewable Royalties and take-private transaction.
• Represented Pine in connection with its acquisition of Properly Inc.
• Represented Gage Growth in connection with its $545 million acquisition by Terrascend Corp.
• Represented The Parent Company in connection with its merger with Gold Flora Corporation.